Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Saving costs in cancer patient management through molecular imaging.
von Gall C, Maniawski P, Verzijlbergen F, Carrio I, Beyer T, Kalemis A. von Gall C, et al. Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2153-2157. doi: 10.1007/s00259-017-3804-3. Epub 2017 Aug 14. Eur J Nucl Med Mol Imaging. 2017. PMID: 28808743 Free PMC article. No abstract available.
Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT.
Wiesmüller M, Quick HH, Navalpakkam B, Lell MM, Uder M, Ritt P, Schmidt D, Beck M, Kuwert T, von Gall CC. Wiesmüller M, et al. Among authors: von gall cc. Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):12-21. doi: 10.1007/s00259-012-2249-y. Epub 2012 Oct 6. Eur J Nucl Med Mol Imaging. 2013. PMID: 23053323
Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M. Quick HH, et al. Among authors: von gall c. Invest Radiol. 2013 May;48(5):280-9. doi: 10.1097/RLI.0b013e3182845a08. Invest Radiol. 2013. PMID: 23442775
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.
Berger AK, Lücke S, Abel U, Haag GM, Grüllich C, Stange A, Dietrich M, Apostolidis L, Freitag A, Trierweiler C, von Gall C, Ose J, Giesel F, Weber TF, Lordick F, Haberkorn U, Jäger D. Berger AK, et al. Among authors: von gall c. Br J Cancer. 2018 Jul;119(2):170-175. doi: 10.1038/s41416-018-0152-4. Epub 2018 Jul 2. Br J Cancer. 2018. PMID: 29961759 Free PMC article. Clinical Trial.
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial.
Berger AK, von Gall C, Abel U, Delorme S, Kloor M, Ose J, Weber TF, Stange A, Haag GM, Haberkorn U, Lordick F, Jäger D. Berger AK, et al. Among authors: von gall c. BMC Cancer. 2012 Mar 22;12:108. doi: 10.1186/1471-2407-12-108. BMC Cancer. 2012. PMID: 22439666 Free PMC article. Clinical Trial.
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW. Lorenzen S, et al. Among authors: von gall c. BMC Cancer. 2011 Jun 24;11:266. doi: 10.1186/1471-2407-11-266. BMC Cancer. 2011. PMID: 21702914 Free PMC article.
Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.
Giesel FL, Runge V, Kirchin M, Mehndiratta A, Gerigk L, Corell B, von Gall C, Kauczor HU, Essig M. Giesel FL, et al. Among authors: von gall c. J Comput Assist Tomogr. 2010 Sep-Oct;34(5):678-83. doi: 10.1097/RCT.0b013e3181e359c2. J Comput Assist Tomogr. 2010. PMID: 20861769
5-HT1A and 5-HT2A receptor effects on recognition memory, motor/exploratory behaviors, emotionality and regional dopamine transporter binding in the rat.
Nikolaus S, Chao OY, Henke J, Beu M, Fazari B, Almeida FR, Abdel-Hafiz L, Antke C, Hautzel H, Mamlins E, Müller HW, Huston JP, von Gall C, Giesel FL. Nikolaus S, et al. Among authors: von gall c. Behav Brain Res. 2024 Jul 9;469:115051. doi: 10.1016/j.bbr.2024.115051. Epub 2024 May 21. Behav Brain Res. 2024. PMID: 38777263 Free article.
78 results